Cardlytics stock: buy or sell?

CDLX stock price: $61.35 -3.69% At close on December 6th, 2019

Updated on:
December 6th, 2019


After several days of continuous rises in past weeks, Cardlytics plummed -3.69% to $61.35.

Cardlytics, Inc. operates purchase data intelligence platforms in the United States and the United Kingdom. The company operates through two segments, Cardlytics Direct and Other Platform Solutions.

Should I buy Cardlytics stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Cardlytics stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean CDLX will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Cardlytics stock a buy?

Financial institutions and banks publish stock ratings everyday. At, we collected 7 ratings published for CDLX stock in the last month.

The general sentiment of these ratings is bullish for CDLX stock, with 7 positive ratings.
Is CDLX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-9SunTrust Banksn/aBuy
2019-8-9Raymond Jamesn/aOutperform
2019-7-24Bank of AmericaBuyBuy
2019-7-1William Blairn/aOutperform
2019-5-6SunTrust Banksn/aBuy
2019-3-6SunTrust Banksn/aBuy

Cardlytics stock analysis

Daily outlook

Cardlytics plummed -3.69% to $61.35 after yesterday all time highs.

After several days of continuous rises in past weeks, Cardlytics plummed -3.69% to $61.35. From a daily perspective, CDLX is in a short term uptrend after plotting its last bottom ($54.52, on November/26) higher than the previous bottom, and its last top ($65.43, yesterday) also over the previous top. Now trading in between its last bottom and last top CDLX might consolidate in a plain range, waiting to break out over $65.43 or down under $54.52. Yesterday, CDLX hit new all time highs, pushing higher previous ATH of $64.42 recorded on Dec/4. New ATHs are usual entry points for many trading setups as there aren't higher resistences. On October CDLX price bounced up over the SMA of 50 days demonstrating to be a significant support for this stock.

CDLX stock chart (daily)

Weekly outlook

Cardlytics shares rocketed 9.46% this week and topped a new all time high at $65.43.

Cardlytics stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, CDLX might consolidate in a flat-base, waiting to break out over or down under . Early June, SMA20w and SMA40w crossed up triggering a rise of 167.32%. Since early May when CDLX stock price broke up the SMA40w line, it gained $44.39 (261.73%).

CDLX stock chart (weekly)

Cardlytics stock price history

Cardlytics stock went public on February 9th, 2018 with a price of $12.101. Since then, CDLX stock grew a 407.00%, with a yearly average of 407.00%. If you had invested right after CDLX's IPO a $1,000 in Cardlytics stock in 2018, it would worth $4,070.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Cardlytics stock historical price chart

CDLX stock reached all-time highs yesterday with a price of $65.43.

Cardlytics stock price target is $30.50

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' CDLX stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 6 price predictions for CDLX stock:
CDLX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-9SunTrust BanksRaises Target$25.00$35.0040%
2019-8-9Raymond JamesRaises Target$24.00$40.0066.7%
2019-7-24Bank of AmericaReiterates$22.00$32.0045.5%
2019-5-6SunTrust BanksReiteratesn/a$25.00-
2019-5-10KeyCorpRaises Target$25.00$26.004%
2019-3-6SunTrust BanksReiteratesn/a$25.00-
(in average)$24.00$30.5027.0%
The price prediction for Cardlytics stock is $30.50, moving in a range between $40.00 and $25.00. In average, analysts' outlook on CDLX price forecast is positive, increasing the prediction by a 27.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Cardlytics reported superb results for 2018-Q4 on March. Cardlytics rose Earnings per Share (EPS) by 18.60%, beating analysts of $-0.43. Cardlytics posted $-0.51.
CDLX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Cardlytics annual revenues skyrocketed an exceptional 15.59% to $150.68 million dollars from $130.37 marked in 2017. When comparing 2018 vs 2017, in contrast, profit margin (that is, the net income divided by revenues) collapsed a -20.13% to -35.20%.

CDLX annual Sales and Income evolution
2015$78 M-$-40.63 M-52.3%-
2016$113 M45.32%$-75.70 M-67.1%86.33%
2017$130 M15.55%$-19.64 M-15.1%-74.05%
2018$151 M15.59%$-53.04 M-35.2%170.06%

Quarterly financial results

Cardlytics reported $47.82 million in revenues for 2018-Q4, a 38.28% improvement compared to previous quarter. Reported quarter earnings marked $-11.57 million with a profit margin of -24.19%. Profit margin stayed stable a 0.01% compared to previous quarter when profit margin was -24.20%. When comparing sales to same quarter last year, Cardlytics sales marked an amazing growth and climbed a 21.78%.
CDLX quarterly Sales and Income evolution
2017-Q1$27 M-$-12.46 M-46.4%-
2017-Q2$33 M22.06%$-0.65 M-2.0%-94.80%
2017-Q3$31 M-4.28%$-2.47 M-7.9%281.79%
2017-Q4$39 M25.03%$-4.06 M-10.3%63.95%
2018-Q1$33 M-16.69%$-20.06 M-61.3%394.45%
2018-Q2$36 M8.73%$-13.05 M-36.7%-34.91%
2018-Q3$35 M-2.78%$-8.37 M-24.2%-35.89%
2018-Q4$48 M38.28%$-11.57 M-24.2%38.22%

Cardlytics ownership

When you are planning to invest in a company, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Cardlytics, 21.49% of all outstanding shares are owned by its staff.

In case of Cardlytics stock, 70.50% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CDLX stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related companies:

Market cap$1.6 B
Total shares25.7 M
Float shares18.9 M
  - Institutional holdings (%)70.5%
  - Insider holdings (%)21.5%
Shares in short selling0.0%

Cardlytics summary

Friday, December 6th, 2019
Day range$61.14 - $64.54
Previous close$63.70
Session gain-3.69%
Average true range$3.25
50d mov avg$44.65
100d mov avg$38.75
200d mov avg$29.47
Daily patternlt06a
Weekly pattern lt06a

Cardlytics performance

To measure stock performance is always good to compare with competitors or related stocks. For Cardlytics, the comparison is made against .

Cardlytics competitors

Unfortunately, we could not find any public company that could be defined as Cardlytics competitor. This doesn't mean Cardlytics does not have any competitor in the market, it's just we could not detected it.